Terms of Use

These Terms of Use govern your use of the FirstWord Pharma newsletter service provided to you by FirstWord Publishing.

If you do not accept these Terms of Use, please do not use the FirstWord Pharma newsletter service. By submitting payment of the applicable fees, if any, and/or by using the FirstWord Pharma newsletter service, you indicate your acceptance to be bound by these Terms of Use.

1. Registration and Security

2. Subscription Fees and Payment

3. Changes to the Terms of Use

4. Renewal

5. Access and Use

6. Restrictions on Use

7. Changes to FirstWord Pharma

8. Cancellation of the FirstWord Pharma newsletter Service

9. Third-party Web Sites, Links, and Information

10. Third Party Advertisers

11. Nature of the Service of Warranties and Limitations on Liability

12. Disclaimers of Warranties and Limitations on Liability

13. Subscriber Indemnification

14. General

  • Registration and Security. You are responsible for providing accurate registration information and for updating it as necessary. Registration information provided by you will be used by FirstWord Publishing in accordance with our Privacy Policy and may be processed in the United States or in any other country where FirstWord Publishing carries out its activities. By subscribing to the FirstWord Pharma newsletter, you consent to the transfer of information outside of your country.
  • Subscription Fees and Payment.
    • You agree to pay the subscription fees and other charges incurred in connection with your subscription to and use of FirstWord Pharma (including any applicable taxes) at the rates in effect when the fees or charges were incurred. Please see Subscription Fees for a list of the current Subscription Fees. All charges will be billed to your credit card.
    • If you are authorized to receive FirstWord Pharma through an arrangement with your employer, some or all of these "Subscription Fees and Payments" terms may not apply to you. Please contact your employer for details.
    • Subscription fees are payable by credit card only. By submitting credit or card payment details to FirstWord Publishing, you warrant that you are entitled to purchase the FirstWord Pharma newsletter services using those payment details. In the case of unauthorized payments FirstWord Publishing reserves the right to suspend or terminate your access to the FirstWord Pharma newsletter. If we do not receive payment authorization or if any authorization is subsequently cancelled, we may immediately terminate or suspend your subscription to the FirstWord Pharma newsletter
    • 30-Day Money-Back Guarantee. If at any time during the first 30 days of your subscription, you notify us by email at customer.service@firstwordpharma.com that you are not entirely satisfied with the FirstWord Pharma newsletter services and would like to cancel your subscription, we will refund your full subscription fee and cancel your subscription.
    • Subscription Fees will be billed at the beginning of your subscription or any renewal. After the first 30-days of your subscription, all subscription fees and charges are nonrefundable. We may change the fees and charges for the next subscription period, by giving you advance notice.
  • Changes to the Terms of Use. We may change the Terms of Use at any time. You will be notified when the revised Terms of Use are prominently displayed in the FirstWord Pharma newsletter or when you are notified by any other means that would make a reasonable person aware of such changes. Your continued use of the FirstWord Pharma newsletter service after such notice constitutes your acceptance of the Terms of Use. These Terms of Use were published on November 11, 2004 and updated February 1, 2012.
  • Renewal. Your subscription shall renew automatically, unless we terminate it or you notify us of your decision to terminate your subscription. You must cancel your subscription before it renews in order to avoid billing of subscription fees for the renewal term to your credit card.
  • Access and Use.
    • The FirstWord Pharma newsletter service is offered in two different versions: (1) FirstWord Pharma; (2) FirstWord Pharma PLUS. Certain sections of the FirstWord Pharma newsletter are only accessible to users who pay to subscribe to FirstWord Pharma PLUS. Once you have completed the subscription process and your card has been authorized for payment, you will be given access to the appropriate FirstWord Pharma newsletter sections.
    • You are responsible for all use, activities, and fees associated with or arising from your use of the FirstWord Pharma newsletter service. You must promptly notify FirstWord Publishing of any unauthorized or unlawful use of the FirstWord Pharma newsletter service.
  • Restrictions on Use.
    • Certain materials available via FirstWord Pharma, including without limitation FirstWord Pharma articles, are the property of FirstWord Publishing, its licensors or their respective owners as indicated. You may not remove or alter the copyright or trademark notice on any material on FirstWord Pharma.
    • You acknowledge that FirstWord Pharma is a service mark of FirstWord Publishing and/or its licensors and you may not use it without written permission from FirstWord Publishing. All trademarks not owned by FirstWord Publishing are the property of their respective owners.
    • You agree not to sell, publish, distribute, retransmit or otherwise provide access to the content received or accessible through the FirstWord Pharma newsletter services to anyone.
    • We reserve the right to terminate or restrict your access to the FirstWord Pharma newsletter service if, in our opinion, your use of the service may violate any laws, infringe upon another person's rights or violate these Terms of Use.
  • Changes to FirstWord. FirstWord Publishing reserves the right to make changes or modifications to FirstWord Pharma, including the manner of delivery and frequency with which FirstWord Pharma is provided to you. If you object to any material change in FirstWord Pharma, you may terminate your subscription by providing us with notice of your intent to do so and receive a pro rata refund for the unused portion of any prepaid term.
  • Cancellation of the FirstWord Pharma Service. FirstWord Publishing may stop the operation of the FirstWord Pharma newsletter service at any time without notice to you. If FirstWord Pharma cancels all or part of any of the FirstWord Pharma service, it shall not incur any liability to you, other than the pro rata refund for the unused portion of any prepaid term.
  • Third-party Web Sites, Links, and Information. The FirstWord Pharma newsletter may contain information, products, and services provided by third parties and links to Internet web sites made available by third parties. These parties may have additional restrictions, terms, and conditions governing use of their content, for which you will be subject to. FirstWord Publishing does not control third-party web sites and FirstWord Publishing does not make any representations or warranties, express or implied, regarding information, products, or services associated with such web sites. The inclusion of any links to third-party web sites and Information in FirstWord Pharma does not constitute or imply an endorsement, authorization, sponsorship, or affiliation by or with FirstWord Publishing with respect to any third party, any third party?s web site or its content, or any information, products, or services provided by a third party.
  • Third Party Advertisers. The FirstWord Pharma newsletter may contain the advertisements of third parties. Any correspondence or any other dealings with advertisers found on FirstWord Pharma are solely between you and such advertiser. You agree that FirstWord Publishing shall not be responsible for any loss or damage of any sort incurred as a result of any such dealings or as the result of the presence of such advertisers on FirstWord Pharma. Moreover, you shall not knowingly or intentionally interfere with the display of such advertisements.
  • Nature of the Service. FirstWord Pharma is an informational service for pharmaceutical professionals and does not constitute any form of medical or healthcare advice, recommendation or representation. No content provided through FirstWord Pharma is intended to be relied on for medical advice, diagnosis or treatment. Please contact a licensed physician, health care provider, or pharmaceutical manufacturer with questions involving a medical condition or treatment. Never disregard medical advice or delay in seeking it because of something you have received or accessed through FirstWord Pharma.
  • Disclaimers of Warranties and Limitations on Liability.

    FirstWord Publishing PROVIDES FIRSTWORD PHARMA SOLELY ON AN "AS IS BASIS," AND MAKES NO WARRANTIES, EXPRESS OR IMPLIED, CONCERNING FIRSTWORD AND EXPRESSLY DISCLAIMS ALL WARRANTIES, INCLUDING BUT NOT LIMITED TO WARRANTIES OF FITNESS FOR A PARTICULAR PURPOSE, WARRANTIES OF MERCHANTABILITY AND WARRANTIES OF TITLE, NON-INFRINGEMENT, AND ACCURACY. IN NO EVENT WILL FIRSTWORD PUBLISHING OR ANY OF ITS AFFILIATES, AGENTS, LICENSORS, SUCCESSORS, ASSIGNS, OR LEGAL REPRESENTATIVES BE LIABLE FOR INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES (INCLUDING, WITHOUT LIMITATION, DAMAGES FOR LOSS OF BUSINESS PROFITS, BUSINESS INTERRUPTION, LOSS OF BUSINESS INFORMATION OR OTHER PECUNIARY LOSS) ARISING DIRECTLY OR INDIRECTLY FROM THE USE OF (OR FAILURE TO USE) OR RELIANCE ON FIRSTWORD PHARMA, EVEN IF FIRSTWORD PUBLISHING HAS BEEN ADVISED OF THE POSSIBILITY THAT SUCH DAMAGES MAY ARISE. FIRSTWORD PUBLISHING DOES NOT GUARANTEE THE ACCURACY, CONTENT, OR TIMELINESS OF FIRSTWORD PHARMA AND FIRSTWORD PUBLISHING SHALL NOT BE LIABLE OR RESPONSIBLE FOR ANY LOSS OR INJURY RESULTING DIRECTLY OR INDIRECTLY FROM THE USE OF, FAILURE TO PROVIDE, DELAY IN RECEIVING, OR RELIANCE ON DATA OR CONTENT CONTAINED THEREIN. In no event shall any liability of FirstWord Publishing, its affiliates, agents, licensors, successors, assigns, or legal representatives, if any, arising out of any kind of legal claim (whether in contract, tort, or otherwise) in any way connected with FirstWord Pharma exceed the amount the Subscriber paid to FirstWord Publishing in connection with FirstWord Pharma in the 12 month period immediately preceding the claim.
  • Subscriber Indemnification. You agree to indemnify, defend, and hold FirstWord Publishing, its affiliates, and their employees, officers, contractors, directors, shareholders, legal representatives, agents, successors, and assigns from and against any and all claims, liabilities, suits, demands, damages, losses, judgments, fines, penalties, interest, costs and expenses (including reasonable attorneys' fees and professional and court costs) directly, indirectly, wholly or partially arising from or relating to any breach of these Terms of Use by you, or any act or omission by you in activities arising from or relating to FirstWord Pharma.
  • General. These Terms of Use contain the final and entire agreement between us regarding your use of the FirstWord Pharma newsletter services and supersedes all previous and contemporaneous oral or written agreements regarding your use of the services. This Agreement is personal to you, which means that you may not assign your rights or obligations under this Agreement to anyone. Any attempted assignment in violation of this paragraph shall be void. These Terms of Use and the relationship between you and FirstWord Publishing shall be governed by and construed in accordance with the laws of the State of New York, as applied to agreements entered into and completely performed in New York. Any action to enforce this Agreement will be brought in the federal or state courts presiding in the State of New York, and all parties to this Agreement expressly agree to be subject to the jurisdiction of such courts. The United Nations Convention on Contracts for the International Sales of Goods shall not apply to this Agreement. If any provision of this Agreement is held unenforceable by a court of competent jurisdiction, that provision shall be enforced to the maximum extent permissible so as to effect the intent of the parties, and the remainder of this Agreement shall continue in full force and effect.